(Q51791363)

English

The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor.

scientific article published in February 2009

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253105%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253105%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253105%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Takehiko Tsuchiya

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253105%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Ken-Ichi Nakahama

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253105%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Yasuyuki Asakawa

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253105%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Toshimitu Maemura

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253105%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Masanobu Tanaka

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253105%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Mineto Morita

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253105%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Ikuo Morita

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253105%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

1 February 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253105%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Gynecological Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253105%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253105%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253105%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

104-109

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253105%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1080%2F09513590802549841

21 January 2018

Tumor angiogenesis: therapeutic implications

1 reference

https://api.crossref.org/works/10.1080%2F09513590802549841

21 January 2018

Tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1080%2F09513590802549841

21 January 2018

Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugs

1 reference

https://api.crossref.org/works/10.1080%2F09513590802549841

21 January 2018

Role of hypoxia in tumor angiogenesis-molecular and cellular angiogenic crosstalk.

1 reference

https://api.crossref.org/works/10.1080%2F09513590802549841

21 January 2018

Pigment epithelium-derived factor: a potent inhibitor of angiogenesis

1 reference

https://api.crossref.org/works/10.1080%2F09513590802549841

21 January 2018

PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity

1 reference

https://api.crossref.org/works/10.1080%2F09513590802549841

21 January 2018

Antiangiogenic property of pigment epithelium-derived factor in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1080%2F09513590802549841

21 January 2018

Wilms' tumor growth is suppressed by antiangiogenic pigment epithelium-derived factor in a xenograft model

1 reference

https://api.crossref.org/works/10.1080%2F09513590802549841

21 January 2018

Two functional epitopes of pigment epithelial-derived factor block angiogenesis and induce differentiation in prostate cancer

1 reference

https://api.crossref.org/works/10.1080%2F09513590802549841

21 January 2018

Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1080%2F09513590802549841

21 January 2018

Pigment epithelium-derived factor is estrogen sensitive and inhibits the growth of human ovarian cancer and ovarian surface epithelial cells.

1 reference

https://api.crossref.org/works/10.1080%2F09513590802549841

21 January 2018

Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia

1 reference

https://api.crossref.org/works/10.1080%2F09513590802549841

21 January 2018

A multi-institutional evaluation of factors predictive of toxicity and efficacy of bevacizumab for recurrent ovarian cancer

1 reference

https://api.crossref.org/works/10.1080%2F09513590802549841

21 January 2018

Identifiers

10.1080/09513590802549841

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253105%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19253105%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51791363&oldid=1250533262"